Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001628280-25-004067
Filing Date
2025-02-05
Accepted
2025-02-05 16:33:33
Documents
1
Period of Report
2025-01-28

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wk-form4a_1738791207.html 4/A  
1 FORM 4/A wk-form4a_1738791207.xml 4/A 4879
  Complete submission text file 0001628280-25-004067.txt   6443
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Bhatt Padmanabh P. (Reporting) CIK: 0001539215 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35518 | Film No.: 25593834